IGM Biosciences Inc (IGMS)
10.03
+0.60
(+6.36%)
USD |
NASDAQ |
May 03, 16:00
10.03
0.00 (0.00%)
After-Hours: 16:08
IGM Biosciences Revenue (TTM): 2.13M for Dec. 31, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 2.13M |
September 30, 2023 | 1.851M |
Date | Value |
---|---|
June 30, 2023 | 1.673M |
March 31, 2023 | 1.591M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
1.591M
Minimum
Mar 2023
2.13M
Maximum
Dec 2023
1.811M
Average
1.762M
Median
Revenue (TTM) Benchmarks
Inotiv Inc | 585.17M |
Synlogic Inc | 3.371M |
BioXcel Therapeutics Inc | 1.38M |
Xilio Therapeutics Inc | -- |
NovaBay Pharmaceuticals Inc | 14.73M |